Switchable immune modulator for tumor-specific activation of anticancer immunity

Immune stimulatory antibodies and cytokines elicit potent antitumor immunity. However, the dose-limiting systemic toxicity greatly hinders their clinical applications. Here, we demonstrate a chemical approach, termed “switchable” immune modulator (Sw-IM), to limit the systemic exposure and therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yu, Xie, Yu-Qing, Van Herck, Simon, Nassiri, Sina, Gao, Min, Guo, Yugang, Tang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442900/
https://www.ncbi.nlm.nih.gov/pubmed/34516776
http://dx.doi.org/10.1126/sciadv.abg7291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442900/
https://www.ncbi.nlm.nih.gov/pubmed/34516776
http://dx.doi.org/10.1126/sciadv.abg7291

Ejemplares similares